3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Sarcoma
17
Rhabdomyosarcoma
14
Wilms Tumor
9
Malignant mesenchymal tumor
7
Gestational Trophoblastic Disease
6
Kidney Neoplasms
5
Neuroectodermal Tumors, Primitive, Peripheral
4
Rhabdomyosarcoma, Embryonal
3
Melanoma
3
Fibrosarcoma
3
Sarcoma, Ewing
2
Rhabdomyosarcoma, Alveolar
2
Ovarian Neoplasms
2
Liposarcoma
2
Hydatidiform Mole
2
Hemangiosarcoma
2
Hemangiopericytoma, Malignant
2
Desmoplastic Small Round Cell Tumor
2
Choriocarcinoma
2
Testicular Neoplasms
1
Teratoma, Ovarian
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Sarcoma, Alveolar Soft Part
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Lymphoma
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Etoposide
30
Carboplatin
30
Cisplatin
23
Ifosfamide
22
Filgrastim
22
Paclitaxel
18
Peripheral Blood Stem Cell Transplantation
16
Bleomycin
13
Cyclophosphamide
11
Radiotherapy
8
Thiotepa
7
Magnetic Resonance Spectroscopy
6
Gemcitabine
6
pegfilgrastim
5
Therapeutics
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Busulfan
5
etoposide phosphate
4
Temozolomide
4
Oxaliplatin
4
Dexamethasone
4
sargramostim
3
Vinblastine
3
Taxes
3
Psychiatric Rehabilitation
3
Polymerase Chain Reaction
3
Methylprednisolone
3
Methods
3
Immunohistochemistry
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Testicular Neoplasms
×
Dactinomycin
×
Clear all
NCT06309732
2024-03-13
GAMEC-II
Queen Mary University of London
Phase 2
Completed
36 enrolled